Cargando…
Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study
Objective To determine the prevalence of financial conflicts of interest among members of panels producing clinical practice guidelines on screening, treatment, or both for hyperlipidaemia or diabetes. Design Cross sectional study. Setting Relevant guidelines published by national organisations in t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191201/ https://www.ncbi.nlm.nih.gov/pubmed/21990257 http://dx.doi.org/10.1136/bmj.d5621 |
_version_ | 1782213630740135936 |
---|---|
author | Neuman, Jennifer Korenstein, Deborah Ross, Joseph S Keyhani, Salomeh |
author_facet | Neuman, Jennifer Korenstein, Deborah Ross, Joseph S Keyhani, Salomeh |
author_sort | Neuman, Jennifer |
collection | PubMed |
description | Objective To determine the prevalence of financial conflicts of interest among members of panels producing clinical practice guidelines on screening, treatment, or both for hyperlipidaemia or diabetes. Design Cross sectional study. Setting Relevant guidelines published by national organisations in the United States and Canada between 2000 and 2010. Participants Members of guideline panels. Main outcome measures Prevalence of financial conflicts of interest among members of guideline panels and chairs of panels. Results Fourteen guidelines met our search criteria, of which five had no accompanying declaration of conflicts of interest by panel members. 288 panel members had participated in the guideline development process. Among the 288 panel members, 138 (48%) reported conflicts of interest at the time of the publication of the guideline and 150 (52%) either stated that they had no such conflicts or did not have an opportunity to declare any. Among 73 panellists who formally declared no conflicts, 8 (11%) were found to have one or more. Twelve of the 14 guideline panels evaluated identified chairs, among whom six had financial conflicts of interest. Overall, 150 (52%) panel members had conflicts, of which 138 were declared and 12 were undeclared. Panel members from government sponsored guidelines were less likely to have conflicts of interest compared with guidelines sponsored by non-government sources (15/92 (16%) v 135/196 (69%); P<0.001). Conclusions The prevalence of financial conflicts of interest and their under-reporting by members of panels producing clinical practice guidelines on hyperlipidaemia or diabetes was high, and a relatively high proportion of guidelines did not have public disclosure of conflicts of interest. Organisations that produce guidelines should minimise conflicts of interest among panel members to ensure the credibility and evidence based nature of the guidelines' content. |
format | Online Article Text |
id | pubmed-3191201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-31912012011-10-13 Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study Neuman, Jennifer Korenstein, Deborah Ross, Joseph S Keyhani, Salomeh BMJ Research Objective To determine the prevalence of financial conflicts of interest among members of panels producing clinical practice guidelines on screening, treatment, or both for hyperlipidaemia or diabetes. Design Cross sectional study. Setting Relevant guidelines published by national organisations in the United States and Canada between 2000 and 2010. Participants Members of guideline panels. Main outcome measures Prevalence of financial conflicts of interest among members of guideline panels and chairs of panels. Results Fourteen guidelines met our search criteria, of which five had no accompanying declaration of conflicts of interest by panel members. 288 panel members had participated in the guideline development process. Among the 288 panel members, 138 (48%) reported conflicts of interest at the time of the publication of the guideline and 150 (52%) either stated that they had no such conflicts or did not have an opportunity to declare any. Among 73 panellists who formally declared no conflicts, 8 (11%) were found to have one or more. Twelve of the 14 guideline panels evaluated identified chairs, among whom six had financial conflicts of interest. Overall, 150 (52%) panel members had conflicts, of which 138 were declared and 12 were undeclared. Panel members from government sponsored guidelines were less likely to have conflicts of interest compared with guidelines sponsored by non-government sources (15/92 (16%) v 135/196 (69%); P<0.001). Conclusions The prevalence of financial conflicts of interest and their under-reporting by members of panels producing clinical practice guidelines on hyperlipidaemia or diabetes was high, and a relatively high proportion of guidelines did not have public disclosure of conflicts of interest. Organisations that produce guidelines should minimise conflicts of interest among panel members to ensure the credibility and evidence based nature of the guidelines' content. BMJ Publishing Group Ltd. 2011-10-11 /pmc/articles/PMC3191201/ /pubmed/21990257 http://dx.doi.org/10.1136/bmj.d5621 Text en © Neuman et al 2011 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Research Neuman, Jennifer Korenstein, Deborah Ross, Joseph S Keyhani, Salomeh Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study |
title | Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study |
title_full | Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study |
title_fullStr | Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study |
title_full_unstemmed | Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study |
title_short | Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study |
title_sort | prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in canada and united states: cross sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191201/ https://www.ncbi.nlm.nih.gov/pubmed/21990257 http://dx.doi.org/10.1136/bmj.d5621 |
work_keys_str_mv | AT neumanjennifer prevalenceoffinancialconflictsofinterestamongpanelmembersproducingclinicalpracticeguidelinesincanadaandunitedstatescrosssectionalstudy AT korensteindeborah prevalenceoffinancialconflictsofinterestamongpanelmembersproducingclinicalpracticeguidelinesincanadaandunitedstatescrosssectionalstudy AT rossjosephs prevalenceoffinancialconflictsofinterestamongpanelmembersproducingclinicalpracticeguidelinesincanadaandunitedstatescrosssectionalstudy AT keyhanisalomeh prevalenceoffinancialconflictsofinterestamongpanelmembersproducingclinicalpracticeguidelinesincanadaandunitedstatescrosssectionalstudy |